JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1051
Arvinas
ARVN
$485M
| $55M | 0.01% |
2,012,443
+45,236
| +2% | +$1.43M |
2018 Q3
18 quarters
|
|
1052
TCW Transform 500 ETF
VOTE
$1.13B
| $54.9M | 0.01% |
1,153,390
+325,887
| +39% | +$15.1M |
2022 Q4
1 quarter
|
|
|
ANSS
1053
DELISTED
Ansys
ANSS
| $54.9M | 0.01% |
164,883
+41,533
| +34% | +$11.7M |
2013 Q2
39 quarters
|
|
1054
Life Time Group Holdings
LTH
$9.16B
| $54.8M | 0.01% |
3,435,721
-688,032
| -17% | -$11.8M |
2021 Q4
5 quarters
|
|
1055
nCino
NCNO
$1.98B
| $54.8M | 0.01% |
2,211,199
+15,779
| +0.7% | +$416K |
2020 Q3
10 quarters
|
|
1056
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$20B
| $54.7M | 0.01% |
1,143,405
-345,808
| -23% | -$16.3M |
2015 Q3
30 quarters
|
|
1057
PUT
Broadcom
AVGO
$1.7T
| $54.7M | 0.01% |
852,000
-994,000
| -54% | -$59.8M |
2018 Q1
20 quarters
|
|
1058
Maravai LifeSciences
MRVI
$1.18B
| $54.5M | 0.01% |
3,890,477
-20,555
| -0.5% | -$295K |
2020 Q4
9 quarters
|
|
1059
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$43.9B
| $54.2M | 0.01% |
162,935
+48,324
| +42% | +$16.1M |
2013 Q2
39 quarters
|
|
1060
PUT
ExxonMobil
XOM
$674B
| $54.1M | 0.01% |
493,700
-738,700
| -60% | -$81.7M |
2014 Q2
35 quarters
|
|
1061
Oshkosh
OSK
$8.26B
| $53.9M | 0.01% |
647,587
+55,542
| +9% | +$5.04M |
2013 Q2
39 quarters
|
|
1062
Broadridge
BR
$17.7B
| $53.8M | 0.01% |
367,080
+89,939
| +32% | +$12.9M |
2013 Q2
39 quarters
|
|
1063
Vanguard Health Care ETF
VHT
$18.8B
| $53.8M | 0.01% |
225,554
-52,460
| -19% | -$12.6M |
2013 Q2
39 quarters
|
|
1064
Natural Resource Partners
NRP
$1.45B
| $53.7M | 0.01% |
1,028,353
-56
| -0% | -$3K |
2016 Q1
28 quarters
|
|
1065
iShares Global Healthcare ETF
IXJ
$4.25B
| $53.5M | 0.01% |
641,942
+41,398
| +7% | +$3.43M |
2014 Q4
33 quarters
|
|
1066
CALL
Salesforce
CRM
$193B
| $53.4M | 0.01% |
267,100
+20,600
| +8% | +$3.48M |
2020 Q2
11 quarters
|
|
|
DOC
1067
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $53.3M | 0.01% |
3,572,415
+1,674,012
| +88% | +$25.3M |
2015 Q4
29 quarters
|
|
1068
VeriSign
VRSN
$26.1B
| $53.3M | 0.01% |
252,285
+128,174
| +103% | +$26.4M |
2013 Q2
39 quarters
|
|
1069
Murphy Oil
MUR
$5.4B
| $53.1M | 0.01% |
1,435,962
+384,880
| +37% | +$15.4M |
2013 Q2
39 quarters
|
|
1070
VanEck Junior Gold Miners ETF
GDXJ
$8.37B
| $52.9M | 0.01% |
1,338,488
+148,379
| +12% | +$5.48M |
2016 Q2
27 quarters
|
|
1071
CALL
Stellantis
STLA
$12.8B
| $52.7M | 0.01% |
2,899,500
+665,000
| +30% | +$11.1M |
2018 Q2
19 quarters
|
|
1072
Starwood Property Trust
STWD
$4.83B
| $52.7M | 0.01% |
2,979,199
+1,046,993
| +54% | +$20.2M |
2013 Q2
39 quarters
|
|
1073
PUT
VanEck Gold Miners ETF
GDX
$26.3B
| $52.6M | 0.01% |
491,300
+360,500
| +276% | +$10.9M |
2013 Q2
39 quarters
|
|
1074
Silicon Laboratories
SLAB
$7.43B
| $52.5M | 0.01% |
299,735
+8,195
| +3% | +$1.38M |
2015 Q4
29 quarters
|
|
1075
BP
BP
$115B
| $52.5M | 0.01% |
1,382,599
-88,865
| -6% | -$3.32M |
2013 Q2
39 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.